<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02313194</url>
  </required_header>
  <id_info>
    <org_study_id>12-001416</org_study_id>
    <nct_id>NCT02313194</nct_id>
  </id_info>
  <brief_title>Spinal Cord Neuromodulation for SCI</brief_title>
  <official_title>Enabling Forelimb Function With Agonist Drug and Epidural Stimulation in SCI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to assess the strategy of using spinal cord stimulation to improve the
      ability to move in spinal cord injured humans.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An epidural stimulation device will be tested to determine if motor function can be improved.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of arm/hand function</measure>
    <time_frame>24 months</time_frame>
    <description>Formal motor testing</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Cervical Spinal Cord Injury</condition>
  <condition>Tetraparesis</condition>
  <condition>Tetraplegia</condition>
  <arm_group>
    <arm_group_label>Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Determine if epidural stimulation can improve motor function.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Epidural Stimulation</intervention_name>
    <description>Determine if epidural stimulation can improve motor function</description>
    <arm_group_label>Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Stable medical condition without cardiopulmonary disease or dysautonomia that would
             contraindicate hand/arm movement

          2. No severe cardiopulmonary diseases such as severe bradycardia, severe autonomic
             dysreflexia, and/or Chronic Obstructive Pulmonary Disease.

          3. No painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore,
             or infection that might interfere with upper extremity training

          4. No clinically significant depression or ongoing drug abuse

          5. No current anti-spasticity medication regimen

          6. Non-progressive SCI above C5

          7. Must not have received botox injections in the prior six months

          8. Be unable to grip or move independently

          9. Be at least one-year post injury

         10. Must be at least 18 years of age

         11. Segmental reflexes remain functional below the lesion

         12. Female subjects of child-bearing potential must not be pregnant and must be using a
             medically acceptable method of contraception

         13. No current implant(s) of neurostimulators, cardiac pacemakers, defibrillators, shunts,
             stents, or aneurysm clips, and must have no future exposure to diathermy following
             implantation

         14. No coagulopathy, cardiac risk factors, or other significant medical risk factors for
             surgery

         15. Must not be involved in another clinical trial

         16. Must not have disorders or conditions that would require MRI monitoring

        Exclusion Criteria:

        None as long as inclusion criteria are met.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel C Lu, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel C Lu, MD PhD</last_name>
    <phone>310-825-4321</phone>
    <email>dclu@mednet.ucla.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCLA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel C Lu, MD PhD</last_name>
      <phone>310-825-4321</phone>
      <email>dclu@mednet.ucla.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2014</study_first_submitted>
  <study_first_submitted_qc>December 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2014</study_first_posted>
  <last_update_submitted>January 26, 2016</last_update_submitted>
  <last_update_submitted_qc>January 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Daniel Lu MD PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Quadriplegia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

